These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30557902)

  • 61. Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults. Potential anti-inflammatory role of apoE in vivo.
    Bach-Ngohou K; Nazih H; Nazih-Sanderson F; Zaïr Y; Le Carrer D; Krempf M; Bard JM
    Int J Obes Relat Metab Disord; 2001 Dec; 25(12):1752-8. PubMed ID: 11781754
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Postheparin plasma lipoprotein lipase and hepatic lipase in diabetes mellitus. Relationship to plasma triglyceride metabolism.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Diabetes; 1977 Jan; 26(1):11-21. PubMed ID: 187516
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
    Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
    HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Apolipoprotein CIII bound to apoB-containing lipoproteins is associated with small, dense LDL independent of plasma triglyceride levels in healthy men.
    Shin MJ; Krauss RM
    Atherosclerosis; 2010 Jul; 211(1):337-41. PubMed ID: 20303494
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Apolipoprotein CIII overexpression exacerbates diet-induced obesity due to adipose tissue higher exogenous lipid uptake and retention and lower lipolysis rates.
    Raposo HF; Paiva AA; Kato LS; de Oliveira HC
    Nutr Metab (Lond); 2015; 12():61. PubMed ID: 26705406
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The association of HDL-apoCIII with coronary heart disease and the effect of statin treatment on it.
    Xiong X; Liu H; Hua L; Zhao H; Wang D; Li Y
    Lipids Health Dis; 2015 Oct; 14():127. PubMed ID: 26452348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
    Oscarsson J; Hurt-Camejo E
    Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Relation between apolipoprotein CIII gene polymorphism and coronary artery disease].
    Liu SK; Mu X; Yang YY; Xu Q; Wang XM; Ding RJ; Zhang ZC
    Zhonghua Yi Xue Za Zhi; 2007 Apr; 87(16):1133-5. PubMed ID: 17672999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Human apoCIII transgenic mice with epicardial adipose tissue inflammation and PRESERVATION of the cardiac plexus.
    Jimenes DR; Teixeira Junior NR; Pereira AV; Berti JA; Barbosa CP; Sant'Ana DMG
    Exp Gerontol; 2021 Jun; 148():111261. PubMed ID: 33647361
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interrelationships between postprandial lipoprotein B:CIII particle changes and high-density lipoprotein subpopulation profiles in mixed hyperlipoproteinemia.
    Saïdi Y; Sich D; Camproux A; Egloff M; Federspiel MC; Gautier V; Raisonnier A; Turpin G; Beucler I
    Metabolism; 1999 Jan; 48(1):60-7. PubMed ID: 9920146
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
    Julius U
    Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5.
    Fruchart-Najib J; Baugé E; Niculescu LS; Pham T; Thomas B; Rommens C; Majd Z; Brewer B; Pennacchio LA; Fruchart JC
    Biochem Biophys Res Commun; 2004 Jun; 319(2):397-404. PubMed ID: 15178420
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Apolipoprotein C-III and hepatic triglyceride-rich lipoprotein production.
    Yao Z; Wang Y
    Curr Opin Lipidol; 2012 Jun; 23(3):206-212. PubMed ID: 22510806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of antisense oligonucleotide therapy against apolipoprotein-CIII in hypertriglyceridemia.
    Gouni-Berthold I
    Atheroscler Suppl; 2017 Nov; 30():19-27. PubMed ID: 29096837
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Secretion of lipid-poor nascent human apolipoprotein apoAI, apoCIII, and apoE by cell clones expressing the corresponding genes.
    Hussain MM; Roghani A; Cladaras C; Zanni EE; Zannis VI
    Electrophoresis; 1991 Apr; 12(4):273-83. PubMed ID: 1906400
    [TBL] [Abstract][Full Text] [Related]  

  • 76. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial.
    Sacks FM; Alaupovic P; Moye LA; Cole TG; Sussex B; Stampfer MJ; Pfeffer MA; Braunwald E
    Circulation; 2000 Oct; 102(16):1886-92. PubMed ID: 11034934
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association of plasma apolipoprotein CIII, high sensitivity C-reactive protein and tumor necrosis factor-α contributes to the clinical features of coronary heart disease in Li and Han ethnic groups in China.
    Chen L; Sun M; Liu H; Ma L; Wang T; Li P; Lin M; Lin H; Chang P; Liu Y
    Lipids Health Dis; 2018 Jul; 17(1):176. PubMed ID: 30053815
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of hepatic insulin expression on lipid metabolism in diabetic mice.
    Qu S; Zhang T; Dong HH
    J Diabetes; 2016 May; 8(3):314-23. PubMed ID: 25851734
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation.
    Kawakami A; Aikawa M; Nitta N; Yoshida M; Libby P; Sacks FM
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):219-25. PubMed ID: 17038637
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Plasma apolipoprotein CI and CIII levels are associated with increased plasma triglyceride levels and decreased fat mass in men with the metabolic syndrome.
    van der Ham RL; Alizadeh Dehnavi R; Berbée JF; Putter H; de Roos A; Romijn JA; Rensen PC; Tamsma JT
    Diabetes Care; 2009 Jan; 32(1):184-6. PubMed ID: 18835943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.